D-JNKI1 is a selective JNK inhibitor [7,8] that protects neuronal cultures against excitotoxicity and induces a high degree of neuroprotection in several models of cerebral ischemia, both in vitro and in vivo[9,10]. This evidence concerns the gene MAPK8 and brain ischemia.